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Abstract This study characterizes the substrate-binding sites
of human salivary K-amylase (HSA) and its Y151M mutant.
It describes the ¢rst subsite maps, namely, the number of sub-
sites, the position of cleavage sites and apparent subsite ener-
gies. The product pattern and cleavage frequencies were deter-
mined by high-performance liquid chromatography, utilizing a
homologous series of chromophore-substituted maltooligosac-
charides of degree of polymerization 3^10 as model substrates.
The binding region of HSA is composed of four glycone and
three aglycone-binding sites, while that of Tyr151Met is com-
posed of four glycone and two aglycone-binding sites. The sub-
site maps show that Y151M has strikingly decreased binding
energy at subsite (+2), where the mutation has occurred (32.6
kJ/mol), compared to the binding energy at subsite (+2) of HSA
(312.0 kJ/mol).
0 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
K-Amylases (EC 3.2.1.1) catalyze the hydrolysis of K-1,4
glycosidic linkages in starch and other related carbohydrates.
These enzymes are ubiquitous in both the plant and the ani-
mal kingdoms and play a key role in carbohydrate metabo-
lism. Human K-amylases of both salivary (HSA) and pancre-
atic (HPA) origins have been extensively studied from the
viewpoint of clinical chemistry because they are important
as indicators in evaluating diseases of pancreas and salivary
glands [1,2]. Furthermore, they are used as targets for drug
design in attempts to treat diabetes, obesity, hyperlipemia and
caries [3]. The overall primary structures of the pancreatic and
salivary K-amylases are highly homologous [4], and high se-
quence identity between the two enzymes is re£ected by a
correspondingly high level of structural similarity [3,5].
K-Amylase is the most abundant enzyme in human saliva
and consists of two major families with several isoenzyme in
each family. Extensive studies referring to the subsite archi-
tecture of HSA [6^8] and related enzymes have generated an
interest in examining the role of individual residues around
the substrate-binding site. The active sites of HSA, HPA and
porcine pancreatic K-amylase (PPA) are very similar in archi-
tecture as derived from the crystal structures of the enzyme:
acarbose complexes [9,10].
In this study we have invoked the popular ‘subsite model’,
which was introduced by Phillips [11], to account for the
enzymatic properties of HSA and the mutant Y151M. The
amylase subsite model [12] depicts the substrate-binding re-
gion of the enzyme to be a tandem array of subsites. Each
subsite is complementary to, and interacts with a substrate
monomer unit. The subsites are labelled from the catalytic
site, with negative numbers for subsites to the left (non-reduc-
ing end side) and positive numbers to the right (reducing end
side) according to the proposed nomenclature of Davies et al.
[13]. There are a number of di¡erent ways in which an olig-
omer substrate can interact with these subsites. A substrate
oligomer can bind non-productively so that a susceptible bond
does not extend over the catalytic amino acids of the enzyme;
alternatively, the substrate can bind productively so that a
susceptible bond lies over the catalytic site, in which case
the bond is cleaved.
The process of quantifying the subsite model is referred to
as subsite mapping. To completely map the binding region of
HSA, we determined the number of subsites, located the po-
sition of the catalytic amino acids within the subsites and
determined the binding energies of each subsite-substrate
monomer unit. Quantitative theories of the action pattern of
amylase in terms of subsite a⁄nities were proposed indepen-
dently by Hiromi et al. [14] and Allen and Thoma [15] and
later by Suganuma et al. [16]. The procedure described by
Allen and Thoma was applied for subsite mapping of HSA
and the mutant Y151M since it is suitable for endo-amylases.
Recently this method was also used for subsite map calcula-
tion of the closely related PPA. The action pattern was deter-
mined both on 2-chloro-4-nitrophenyl (CNP)-L-glycosides and
maltooligosaccharides. Computer modelling on the two di¡er-
ent maltooligosaccharide series resulted in the same subsite
map for PPA, which veri¢es that the presence of CNP group
at the reducing end of substrates does not in£uence the ap-
parent binding energies [17]. In addition, there are some sub-
site maps published in the literature for distantly related amy-
lases, e.g. from Aspergillus oryzae, Bacillus licheniformis
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(BLA) and Thermoactinomyces vulgaris, which clearly show
the di¡erences in the binding region of these enzymes
[15,18,19].
The active site of human amylases harbors three aromatic
residues Trp59, Tyr62 and Tyr151, which provide stacking
interactions to the bound glucose moieties. It has already
been shown that Tyr151 occurs at subsite (+2) and may in-
£uence the size of the leaving group. To study the role of
subsite (+2) in recognition of terminal residue of substrate a
mutant Y151M was generated in which the tyrosine at posi-
tion 151 of HSA was replaced by a methionine [20].
Present studies were aimed at evaluating the subsite maps of
HSA and Y151M mutant by utilizing as model substrates
CNP-L-glycosides of maltooligosaccharides with varying de-
gree of polymerization (DP) 3^10. A computer program,
which was developed by Gye¤ma¤nt et al. [17] according to
the synopsis of Allen and Thoma [15], was used for subsite
mapping of HSA and the Y151M mutant.
2. Materials and methods
2.1. Enzymes
K-Amylase (EC 3.2.1.1) from human saliva (Type IXA Sigma) gave
a single band on sodium dodecyl sulfate^polyacrylamide gel electro-
phoresis (SDS^PAGE) and possessed no K- and L-glycosidase activity.
The mutant Y151M enzyme was produced as previously described
[20].
The Y151M enzyme was puri¢ed by a combination of ion exchange
chromatography and size exclusion chromatography (data not
shown). The SDS^PAGE and Western blot analyses showed a very
intense band of approximate size 55 kDa in the culture medium cor-
responding to the recombinant enzyme. As with the expression of
wild-type enzyme, hexosamines were not detected in the amino acid
analysis indicating that the expressed protein was non-glycosylated.
Approximately 5 mg of the protein was ¢nally recovered from 1 l
culture comparable to the amount recovered for HSA. MALDI-
TOF MS (matrix-assisted laser desorption/ionization time-of-£ight
mass spectrometry) analysis of the mutant showed a molecular mass
of 56.22 kDa corresponding to non-glycosylated enzyme.
2.2. Substrates
CNP-L-maltooligosaccharides DP 3^7 were synthesized from L-cy-
clodextrin [21]. The longer chain length of CNP-maltooligosacchar-
ides in the range of DP 8^10 was prepared by a chemoenzymatic
procedure described earlier by Kandra et al. [22].
2.3. Hydrolysis of maltooligosides
Incubations in 25 mM glycerophosphate bu¡er (pH 7.0) containing
5 mM Ca(OAc)2 and 50 mM NaCl were carried out at 37‡C for 2, 5
and 10 min. The reactions were initiated by the addition of enzyme
(¢nal concentration of 1.85 nM HSA and 18.8 nM Y151M) to the
solution containing 1.0 mM of substrate. Samples (20 Wl) were taken
at the indicated time intervals and the reaction was stopped by the
injection of the samples into the chromatographic column. In these
studies we have taken care to exclude the secondary attack on the
products by obtaining the product ratios from the early stages of
hydrolysis wherein the conversion was always 6 10%.
Catalytic e⁄ciencies which were calculated from the hydrolysis data
measured with CNP-G7 substrate by high-performance liquid chro-
matography (HPLC) show that Y151M has remarkably decreased
a⁄nity (kcat/KM : 106 s31 mM31) compared to the catalytic e⁄ciency
of HSA (kcat/KM : 2678 s31 mM31).
2.4. Chromatographic analysis
For HPLC a Hewlett-Packard 1090 Series II liquid chromatograph
equipped with a diode array detector, automatic sampler and Chem-
Station was used. The samples were separated on Spherisorb ODS2 5
Wm column (250U4.0 mm) with acetonitrile:water (13:87) as the mo-
bile phase and at a £ow rate of 1 ml/min at 40‡C. The e¥uent was
monitored for CNP-glycosides at 302 nm and the products of the
hydrolysis were identi¢ed by using relevant standards (Fig. 1).
3. Results and discussion
The application of homologous oligomeric substrates is an
e¡ective way to explore the nature of the binding site and the
process of catalysis for K-amylases. Although the overall
structure and the tertiary folding of the polypeptide chains
of di¡erent K-amylases have been determined [23], less is
known about the di¡erences in the action of K-amylases on
the homologous maltooligosaccharide series and only a few
subsite maps have been evaluated for K-amylases until now
[15,16,18,19,24]. The use of L-CNP-maltooligosacharides as
probes for subsite mapping has been successful in the study
of the action pattern and subsite mapping of PPA and BLA
(B. licheniformis K-amylase) [17,25], albeit small di¡erences
that might be expected from the true subsite map due to
perturbation caused by the L-linked chromophore residue.
Compared with other substrate series so far reported, for
example, maltooligosaccharides [26] or K-NP-maltooligosac-
charides [27], the CNP-maltooligosaccharides, which are
L-glycosides, are unique since the L-linkage is stable and is
not hydrolyzed by K-amylases. Therefore, the reducing end
products of hydrolysis are always L-glycosides and lead to
clear identi¢cation of the site of cleavage using UV detection.
3.1. Action pattern and cleavage frequencies of HSA on
CNP-maltooligosides
A series of CNP-maltooligosaccharides DP 3^10 was used
Table 1
Yields of products from the hydrolysis of CNP-maltooligosaccharides by HSA
Substrate Products (mol%)
CNP-G1 CNP-G2 CNP-G3 CNP-G4 CNP-G5 CNP-G6 CNP-G7
CNP-G3 ^ ^
CNP-G4 10 85 5
CNP-G5 2 86 12
CNP-G6 51 44 5
CNP-G7 18 50 30 2
CNP-G8 16 27 41 16
CNP-G9 17 19 26 30 8
CNP-G10 17 29 16 11 19 8
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as substrates for HSA and the products were analyzed using
HPLC to determine unambiguously the exact glycosidic link-
age being cleaved, as well as the cleavage frequency, an in-
dicator of the binding mode of the corresponding substrate.
The chromatographic conditions are given in Section 2. The
products containing the CNP moiety were quanti¢ed using a
diode array detector at 302 nm. The concentrations of glyco-
sidic fragments produced by amylase reaction showed linear-
ity with the reaction time, and the distribution of products
was calculated for a given substrate. Table 1 summarizes the
product ratios for HSA.
HSA exhibits a unique pattern of action on CNP-malto-
oligosaccharides by cleaving CNP-G2 units as the main prod-
ucts; 85%, 86% and 51% from the reducing end of CNP-G4,
CNP-G5 and CNP-G6, respectively. As the chain length in-
creases, the maximum frequency of attack shifts toward the
non-reducing end of the chain and a more equal distribution
between the potential products of longer substrates is ob-
served. Nevertheless, the release of maltotetraose is always
dominant; 51%, 50%, 41% and 30% from CNP-G6, CNP-
G7, CNP-G8 and CNP-G9, respectively.
The number of subsites in HSA has been reported to be ¢ve
based on kinetic data measured with modi¢ed oligosaccha-
rides [7,8]. In this model, the subsite architecture consists of
three glycone and two aglycone subsites. In a later study,
Nagamine et al. [28] proposed that there are seven subsites
in tandem. Based on crystal structure analysis, it was sug-
gested that the active site of HSA could consist of up to seven
subsites [3]. Recently the action pattern of oligosaccharides
shorter than heptaose was explained by the ¢ve subsite model,
while for the interpretation of results from heptaose hydroly-
sis, additional subsites were invoked [20]. The recent report on
the acarbose complexes of HSA and a deletion mutant (lack-
ing residues 306^310 of HSA) shows that the hexasaccharide
was bound at the active site of native enzyme while a hepta-
saccharide was present in a deletion mutant [10]. Present study
con¢rms that the binding region in HSA is longer than ¢ve
subsites, and strongly suggests the presence of at least seven
subsites; four glycone- and three aglycone-binding sites at the
reducing end.
3.2. Action pattern and cleavage frequencies of Y151M on
CNP-maltooligosides
The product distribution for Y151M mutant, on the same
oligosaccharide series, was very interesting and markedly dif-
ferent from that of the HSA (Table 2). The moiety CNP-G1 is
the major product of hydrolysis when CNP-G3 and CNP-G4
were used as substrates. Thus, hydrolysis of CNP-G3, CNP-
G4 and CNP-G5 resulted in 77%, 76% and 34% CNP-G1
compared to 0%, 10% and 2% CNP-G1 when HSA was
used as a catalyst. There is marked reduction in the amount
of CNP-G2 produced in the hydrolysis of CNP-G4 and CNP-
G5 catalyzed by HSA (85% and 86% CNP-G2, respectively,
vs. 17% and 54%, respectively for Y151M) (Tables 1 and 2).
This suggests a favorable interaction between the glucose moi-
ety and subsite (+1), but a less favorable one between the
glucose residue and subsite (+2).
The moiety CNP-G1 was signi¢cantly released in the hy-
drolysis of longer oligomers (DP 6^10) as well whereas this
monomer glycoside was not recognizable as a product in the
hydrolysis of the corresponding substrates by HSA. In this
mutant the point of cleavage moved closer to the reducing
end by one subsite resulting in a clear shift in the action
pattern. This tendency is evident for all of the substrates
DP 3^10. These results can be explained by the presence of
methionine at subsite (+2) which is not advantageous to the
polar glucose residues. This residue may not provide as strong
Table 2
Yields of products from the hydrolysis of CNP-maltooligosaccharides by Y151M
Substrate Products (mol%)
CNP-G1 CNP-G2 CNP-G3 CNP-G4 CNP-G5 CNP-G6 CNP-G7
CNP-G3 77 23
CNP-G4 76 17 7
CNP-G5 34 54 4 8
CNP-G6 10 63 26 1
CNP-G7 8 25 33 34
CNP-G8 10 18 17 38 17
CNP-G9 8 30 14 18 24 6
CNP-G10 7 16 25 11 11 15 15
Fig. 1. HPLC chromatogram of CNP-G8 hydrolysis products cata-
lyzed by HSA and Y151M mutant. Injected volume: 20 Wl.
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a stacking and/or hydrophobic interaction as that of the ty-
rosine present in the wild-type enzyme.
3.3. Subsite mapping of HSA and Y151M
Endo-acting enzymes form more productive binding modes
resulting in a complex product pattern. The relative rate of
formation of each product is called bond cleavage frequency
(BCF), which gives information about the subsite-binding en-
ergy. By using BCFs for a series of oligomeric substrates, it is
possible to calculate the subsite-binding energy for each sub-
site on the enzyme-binding region, with the exception of the
two subsites adjacent to the catalytic site which are occupied
by all productive complexes.
The preferred procedure suggested by Allen and Thoma
[13] for subsite map calculation is as follows:
b Establish experimental conditions where secondary reac-
tions (transglycosylation, secondary attack) are insigni¢-
cant.
b Use end-labelled substrates to determine quantitative BCF
for chain lengths that are large enough to span the entire
binding region.
b Examine BCSs to estimate the number of subsites and the
position of the catalytic site.
b Apply a minimization process to test the di¡erences of mea-
sured and calculated BCF data.
Fig. 2 shows the apparent binding energies of subsites for
HSA and Y151M.
Subsite map shows that four glycone and three aglycone
binding sites are present in HSA. Subsite (+3) has a moderate
but signi¢cant a⁄nity for the glucose residue (31.5 kJ/mol)
and therefore it is reasonable to consider the presence of the
third subsite at the aglycone site. This subsite does not exist in
Y151M. To clarify the presence of subsite (+3) further struc-
tural and biochemical investigations are necessary. Surpris-
ingly, the calculated binding energy at subsite (+2) (312.0
kJ/mol) indicates a remarkably good interaction with the
bound monomer unit compared with the other subsite ener-
gies. This ¢nding is in good agreement with the three-dimen-
sional structural model of HSA described by Ramasubbu et
al. [10]. Fig. 3 shows the three-dimensional structure of the
active site of HSA and bound inhibitor at subsite (+2).
Although a decreased binding energy was envisaged for
subsite (+2) in Y151M, all of the subsites exhibited a lower
a⁄nity for a glucose residue compared to the corresponding
subsites of HSA. Such a reduction ¢ts well with cooperative
binding of the oligosaccharide ligand. The most remarkable
decrease in the calculated binding energies can be found at
subsite (+2), 32.6 kJ/mol compared to 312.0 kJ/mol when
HSA was used. These ¢ndings con¢rm clearly the role of
Tyr151 at subsite (+2) and provide evidence that stacking
interactions at the reducing end are important in substrate
binding and product distribution in the hydrolysis of oligo-
saccharides catalyzed by HSA. The methionine at position 151
Fig. 2. Subsite maps for HSA (solid bar) and Y151M (open bar). The arrow indicates the scissile bond. The reducing end of maltooligomers is
situated at the right hand of the subsite map. Negative energy values indicate binding between the enzyme and aligned glucopyranosyl residues,
while positive values indicate repulsion.
Fig. 3. Stereodiagram of the active center of HSA. The interaction
around subsite (+2) in HSA is shown. The residue Tyr151 interacts
with subsite glucose through both a stacking interaction and a water
molecule. In addition to its interaction with Tyr151, the glucose
also has hydrogen-bonding interactions with Lys200 and Glu240.
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of HSA would not provide the stacking interaction and the
water-mediated hydrogen-bonding interaction provided by the
tyrosine residue of HSA. However, the interactions provided
by Glu240 and Lys200 would be expected to be present. The
considerable reduction in the a⁄nity at subsite (+2) in the
mutant suggests that the stacking interaction should be
present. The interactions with Lys200 and Glu240 may be
secondary which come into play later. Thus, the disappear-
ance of the a⁄nity at subsite (+3) may be dependent upon the
absence of several interactions at subsite (+2). The subsite
(+3) appears to be more solvent exposed than (+2) as deduced
from the crystal structure of the HSA:acarbose complex [10],
which also could account for the relatively smaller reduction
in the a⁄nity. Nevertheless, the involvement of Tyr151 may
be signi¢cant in the hydrolysis mechanism of HSA since the
productive binding modes for oligosaccharides include the one
in which a glucose unit occupies this site. The results of this
study show signi¢cant di¡erences in the active site architecture
of the wild-type and the mutant. The reduction in the a⁄nity
may arise due to the side of methionine adopting a conforma-
tion, which partially occupies the space which would other-
wise be occupied by a glucose.
The tyrosine residue at position 151 of HSA is highly con-
served in all mammalian amylases and those which contain a
chloride ion near the active site [29]. A tyrosine residue of
similar function exists at position 139 in Tenebrio molitor
K-amylase, as well [30].
In summary, the tyrosine residue at position 151 of HSA
appears to play a major role in the hydrolysis of CNP-sub-
strates by not only a¡ecting the ground state binding but also
transition state a⁄nities of the substrates.
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